Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so
Douglas B. Kell, Paul D. Dobson, Elizabeth Bilsland, et al.
Drug Discovery Today (2012) Vol. 18, Iss. 5-6, pp. 218-239
Closed Access | Times Cited: 147

Showing 51-75 of 147 citing articles:

Individuality, phenotypic differentiation, dormancy and ‘persistence’ in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology
Douglas B. Kell, Marnie Potgieter, Etheresia Pretorius
F1000Research (2015) Vol. 4, pp. 179-179
Open Access | Times Cited: 43
Drug Discovery for Chagas Disease: Impact of Different Host Cell Lines on Assay Performance and Hit Compound Selection
Caio Haddad Franco, Laura Maria Alcântara, Eric Chatelain, et al.
Tropical Medicine and Infectious Disease (2019) Vol. 4, Iss. 2, pp. 82-82
Open Access | Times Cited: 41
Involvement of multiple influx and efflux transporters in the accumulation of cationic fluorescent dyes by Escherichia coli
Srijan Jindal, Lei Yang, Philip J. Day, et al.
BMC Microbiology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 39
An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines
Marina Wright Muelas, Ivayla Roberts, Farah Mughal, et al.
Metabolomics (2020) Vol. 16, Iss. 10
Open Access | Times Cited: 37
The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes
Douglas B. Kell
Molecules (2021) Vol. 26, Iss. 18, pp. 5629-5629
Open Access | Times Cited: 28
A protet-based model that can account for energy coupling in oxidative and photosynthetic phosphorylation
Douglas B. Kell
Biochimica et Biophysica Acta (BBA) - Bioenergetics (2024) Vol. 1865, Iss. 4, pp. 149504-149504
Open Access | Times Cited: 4
Five Key Criteria for Identifying Optimal Therapeutic Targets in Protein‐Mediated Diseases
Mohammed Baqur S. Al‐Shuhaib, Jafar M. B. Al‐Shuhaib
ChemistrySelect (2025) Vol. 10, Iss. 4
Closed Access
Understanding, inhibiting, and engineering membrane transporters with high-throughput mutational screens
Steven T. Miller, Christian B. Macdonald, Srivatsan Raman
Cell chemical biology (2025)
Closed Access
Methodologies to Assess Drug Permeation Through the Blood–Brain Barrier for Pharmaceutical Research
Céline Passeleu-Le Bourdonnec, Pierre‐Alain Carrupt, J M Scherrmann, et al.
Pharmaceutical Research (2013) Vol. 30, Iss. 11, pp. 2729-2756
Open Access | Times Cited: 44
An analysis of a ‘community-driven’ reconstruction of the human metabolic network
Neil Swainston, Pedro Mendes, Douglas B. Kell
Metabolomics (2013) Vol. 9, Iss. 4, pp. 757-764
Open Access | Times Cited: 42
Drug delivery: A process governed by species-specific lipophilicities
Károly Mazák, Béla Noszál
European Journal of Pharmaceutical Sciences (2014) Vol. 62, pp. 96-104
Closed Access | Times Cited: 37
Advances in microspeciation of drugs and biomolecules: Species-specific concentrations, acid-base properties and related parameters
Károly Mazák, Béla Noszál
Journal of Pharmaceutical and Biomedical Analysis (2016) Vol. 130, pp. 390-403
Closed Access | Times Cited: 37
Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites
Steve O’Hagan, Douglas B. Kell
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 36
Modeling the effects of commonly used drugs on human metabolism
Swagatika Sahoo, Hulda S. Haraldsdóttir, Ronan M. T. Fleming, et al.
FEBS Journal (2014) Vol. 282, Iss. 2, pp. 297-317
Open Access | Times Cited: 32
Analysing and Navigating Natural Products Space for Generating Small, Diverse, But Representative Chemical Libraries
Steve O’Hagan, Douglas B. Kell
Biotechnology Journal (2017) Vol. 13, Iss. 1
Open Access | Times Cited: 32
Fitting Transporter Activities to Cellular Drug Concentrations and Fluxes: Why the Bumblebee Can Fly
Pedro Mendes, Stephen G. Oliver, Douglas B. Kell
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 11, pp. 710-723
Open Access | Times Cited: 31
Design, Synthesis and Antifungal Activity Evaluation of New Thiazolin-4-ones as Potential Lanosterol 14α-Demethylase Inhibitors
Anca Stana, Dan Cristian Vodnar, Radu Tamaian, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 1, pp. 177-177
Open Access | Times Cited: 30
pH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive Diffusion
Yi Zheng, Leslie Z. Benet, Hideaki Okochi, et al.
Pharmaceutical Research (2015)
Open Access | Times Cited: 29
Analysis of drug–endogenous human metabolite similarities in terms of their maximum common substructures
Steve O’Hagan, Douglas B. Kell
Journal of Cheminformatics (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 29
MetMaxStruct: A Tversky-Similarity-Based Strategy for Analysing the (Sub)Structural Similarities of Drugs and Endogenous Metabolites
Steve O’Hagan, Douglas B. Kell
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 28
Current Advances in Studying Clinically Relevant Transporters of the Solute Carrier (SLC) Family by Connecting Computational Modeling and Data Science
Alžběta Türková, Barbara Zdrazil
Computational and Structural Biotechnology Journal (2019) Vol. 17, pp. 390-405
Open Access | Times Cited: 26
A palette of fluorophores that are differentially accumulated by wild-type and mutant strains of Escherichia coli: surrogate ligands for profiling bacterial membrane transporters
J. Enrique Salcedo-Sora, Srijan Jindal, Steve O’Hagan, et al.
Microbiology (2021) Vol. 167, Iss. 2
Open Access | Times Cited: 22
Transport Inhibition of Digoxin Using Several Common P-gp Expressing Cell Lines Is Not Necessarily Reporting Only on Inhibitor Binding to P-gp
Annie Lumen, Libin Li, Jiben Li, et al.
PLoS ONE (2013) Vol. 8, Iss. 8, pp. e69394-e69394
Open Access | Times Cited: 29
A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood‐retinal barrier
Hélène Chapy, Pascal André, Xavier Declèves, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 19, pp. 4714-4725
Open Access | Times Cited: 28
The Permeability of an Artificial Membrane for Wide Range of pH in Human Gastrointestinal Tract: Experimental Measurements and Quantitative StructureActivity Relationship
Mare Oja, Uko Maran
Molecular Informatics (2015) Vol. 34, Iss. 6-7, pp. 493-506
Closed Access | Times Cited: 25

Scroll to top